Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current status of precision oncology in adult glioblastoma.
Weller J, Potthoff AL, Zeyen T, Schaub C, Duffy C, Schneider M, Herrlinger U. Weller J, et al. Among authors: schneider m. Mol Oncol. 2024 Dec;18(12):2927-2950. doi: 10.1002/1878-0261.13678. Epub 2024 Jun 20. Mol Oncol. 2024. PMID: 38899374 Free PMC article. Review.
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma.
Henrik Heiland D, Ravi VM, Behringer SP, Frenking JH, Wurm J, Joseph K, Garrelfs NWC, Strähle J, Heynckes S, Grauvogel J, Franco P, Mader I, Schneider M, Potthoff AL, Delev D, Hofmann UG, Fung C, Beck J, Sankowski R, Prinz M, Schnell O. Henrik Heiland D, et al. Among authors: schneider m. Nat Commun. 2019 Jun 11;10(1):2541. doi: 10.1038/s41467-019-10493-6. Nat Commun. 2019. PMID: 31186414 Free PMC article.
Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide.
Potthoff AL, Heiland DH, Evert BO, Almeida FR, Behringer SP, Dolf A, Güresir Á, Güresir E, Joseph K, Pietsch T, Schuss P, Herrlinger U, Westhoff MA, Vatter H, Waha A, Schneider M. Potthoff AL, et al. Among authors: schneider m. Cancers (Basel). 2019 Jun 20;11(6):858. doi: 10.3390/cancers11060858. Cancers (Basel). 2019. PMID: 31226836 Free PMC article.
Impact of initial midline shift in glioblastoma on survival.
Wach J, Hamed M, Schuss P, Güresir E, Herrlinger U, Vatter H, Schneider M. Wach J, et al. Among authors: schneider m. Neurosurg Rev. 2021 Jun;44(3):1401-1409. doi: 10.1007/s10143-020-01328-w. Epub 2020 Jun 4. Neurosurg Rev. 2021. PMID: 32494988
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Tzaridis T, Schäfer N, Weller J, Steinbach JP, Schlegel U, Seidel S, Sabel M, Hau P, Seidel C, Krex D, Goldbrunner R, Tonn JC, Grauer O, Kebir S, Schneider M, Schaub C, Vatter H, Coch C, Glas M, Fimmers R, Pietsch T, Reifenberger G, Herrlinger U, Felsberg J. Tzaridis T, et al. Among authors: schneider m. Int J Cancer. 2021 Apr 1;148(7):1695-1707. doi: 10.1002/ijc.33363. Epub 2020 Nov 10. Int J Cancer. 2021. PMID: 33113214 Clinical Trial.
7,437 results